Profiling gene expression in the human dentate gyrus granule cell layer reveals insights into schizophrenia and its genetic risk.
Andrew E JaffeDaniel J HoeppnerTakeshi SaitoLou T BlanpainJoy UkaigweEmily E BurkeLeonardo Collado-TorresRan TaoKatsunori TajindaKristen R MaynardMatthew N TranKeri MartinowichAmy Deep-SoboslayJoo Heon ShinJoel E KleinmanDaniel R WeinbergerMitsuyuki MatsumotoThomas M HydePublished in: Nature neuroscience (2020)
Specific cell populations may have unique contributions to schizophrenia but may be missed in studies of homogenate tissue. Here laser capture microdissection followed by RNA sequencing (LCM-seq) was used to transcriptomically profile the granule cell layer of the dentate gyrus (DG-GCL) in human hippocampus and contrast these data to those obtained from bulk hippocampal homogenate. We identified widespread cell-type-enriched aging and genetic effects in the DG-GCL that were either absent or directionally discordant in bulk hippocampus data. Of the ~9 million expression quantitative trait loci identified in the DG-GCL, 15% were not detected in bulk hippocampus, including 15 schizophrenia risk variants. We created transcriptome-wide association study genetic weights from the DG-GCL, which identified many schizophrenia-associated genetic signals not found in transcriptome-wide association studies from bulk hippocampus, including GRM3 and CACNA1C. These results highlight the improved biological resolution provided by targeted sampling strategies like LCM and complement homogenate and single-nucleus approaches in human brain.
Keyphrases
- single cell
- genome wide
- rna seq
- bipolar disorder
- gene expression
- dna methylation
- copy number
- endothelial cells
- cerebral ischemia
- cell therapy
- cognitive impairment
- magnetic resonance
- poor prognosis
- prefrontal cortex
- stem cells
- machine learning
- computed tomography
- high resolution
- magnetic resonance imaging
- long non coding rna
- mass spectrometry
- drug delivery
- pluripotent stem cells
- case control